Contact: Richard D. Ackerman, President, Pro-Family Law Center, 951-308-6454
SACRAMENTO, Mar. 14 /Standard Newswire/ -- Pro-family advocacy groups won a battle in a heated skirmish over whether parents ought to have a say-so about a mandatory vaccination for HPV (human papilloma virus) proposed by California Assembly Member Ed Hernandez (D) through Assembly Bill 16.
After a flurry of testimony and written analyses by the groups, the bill was voluntarily tabled by Dr. Hernandez after approval and motion by the Chairman of the Assembly Health Committee during yesterday's hearing. A vote on AB16, following anticipated amendments consistent with the concerns of parents-rights advocates, will take place in April of this year. The Assembly Health Committee consists of 15 members, most of whom are Democrats.
Representatives of Traditional Values Coalition, Campaign for Children and Families, Pro-Family Law Center, California Family Council, Capitol Resource Institute, and Dr. Angela Griffiths all testified in opposition to the bill which would have mandated vaccination for HPV, a sexually transmitted disease, before a girl could move on to the seventh grade. The California Catholic Conference and others also weighed in on the issue through written opposition. The unprecedented mandate was proposed to be applicable to all private and public schools and Merck Pharmaceuticals was and is pushing the use of the vaccine for girls as young as nine. Merck would have likely made billions had the vaccine been forced onto
Among other things pointed out by the groups, the Pro-Family Law Center stated in its written legislative analysis that, "According to information published by the CDC and Merck Pharmaceuticals, it appears that Gardisil was only tested worldwide on approximately 25,000 people between the ages of 9 and 26. According to the
PFLC president, Rich Ackerman testified to the Committee that, "I will not allow my daughter to be a guinea pig for the state. As a parent, I am entitled to full disclosure as to the risks presented by this vaccine that has only been out on the market for a year."
Ackerman further states, "I am so incredibly happy that